Online Inquiry
PIK3CA (H1047R/+) Cell Line
SPL-02550
| Size | Price |
| 1 Unit | Online Inquiry |
| Description |
|---|
| PIK3CA (H1047R/+) |
| Target Information | |
|---|---|
| Target Name | PI3K |
| Gene Abbr. | PIK3CA |
| Gene ID | 5290 |
| Full Name | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| Alias | CLAPO, CLOVE, CWS5, MCAP, MCM |
| Species | Human |
| Introduction | Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]. |
| Product Details | |
|---|---|
| Cell Line Model | VACO 432 |
| Genotype | PIK3CA (H1047R/+) |
| Description | PIK3CA (H1047R/+) |
| Disease | Dukes B2 |
| Tissue | colon |
| Gender | Female |
| Key Endogenous Mutations | BRAF |
| CVT Selection Condition | G418 resistant - 0.3 mg/mL |
| Cell Number | 2x10^6 |
| Handling Specifications | |
|---|---|
| Revival | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 3-5 days. Split at 80-90% confluency, approximately 1:2-1:6. |
| Culture Medium | RPMI 1640 including 2 mM L-glutamine and 25 mM sodium bicarbonate, supplemented with 10% FBS. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 3-5 days. Split at 80-90% confluency, approximately 1:2-1:6. |
| Freeze Medium | Complete growth media 45% + USDA approved FBS 50% + DMSO 5% |
| Biosafety Level | BSL-1 |
| Disclaimer | This product is classified under IATA regulations as a GMMO (genetically modified micro-organism) and will ship as UN3245. If applicable, ensure facility meets all requirements per local and country regulations. |
For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.